TARGET BP I Clinical Trial

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

July 22, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

May 31, 2026

Conditions
Hypertension
Interventions
DRUG

Dehydrated alcohol

Dehydrated Alcohol Injection, USP is used in the study.

DEVICE

Peregrine System Kit (Sham Procedure)

Pre-procedural diagnostic renal angiography only, performed for confirmation of anatomical eligibility prior to randomization

Trial Locations (5)

27157

Wake Forest University Baptist Medical Center, Winston-Salem

27607

NC Heart and Vascular Research, Raleigh

30309

Piedmont Heart Institute, Atlanta

35211

Cardiology PC, Birmingham

75390

UT Southwestern Medical Center, Dallas

Sponsors
All Listed Sponsors
lead

Ablative Solutions, Inc.

INDUSTRY